PK of Midazolam with/without Crobenetine in Healthy Males

Phase 1, randomised, single-blind trial in ischemic stroke and neuropathic pain comparing Midazolam and crobenetine with Midazolam and placebo (2 arms). Primary endpoints: Area under the concentration-time curve of midazolam from zero time extrapolated to infinity up to 24 hours and Maximum observed concentration of midazolam in plasma up to 24 hours. Started Feb 2002; status: completed.